Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 13;7(1):54.
doi: 10.1186/s13073-015-0171-1. eCollection 2015.

Secondary findings and carrier test frequencies in a large multiethnic sample

Affiliations

Secondary findings and carrier test frequencies in a large multiethnic sample

Tomasz Gambin et al. Genome Med. .

Abstract

Background: Besides its growing importance in clinical diagnostics and understanding the genetic basis of Mendelian and complex diseases, whole exome sequencing (WES) is a rich source of additional information of potential clinical utility for physicians, patients and their families. We analyzed the frequency and nature of single nucleotide variants (SNVs) considered secondary findings and recessive disease allele carrier status in the exomes of 8554 individuals from a large, randomly sampled cohort study and 2514 patients from a study of presumed Mendelian disease having undergone WES.

Methods: We used the same sequencing platform and data processing pipeline to analyze all samples and characterized the distributions of reported pathogenic (ClinVar, Human Gene Mutation Database (HGMD)) and predicted deleterious variants in the pre-specified American College of Medical Genetics and Genomics (ACMG) secondary findings and recessive disease genes in different ethnic groups.

Results: In the 56 ACMG secondary findings genes, the average number of predicted deleterious variants per individual was 0.74, and the mean number of ClinVar reported pathogenic variants was 0.06. We observed an average of 10 deleterious and 0.78 ClinVar reported pathogenic variants per individual in 1423 autosomal recessive disease genes. By repeatedly sampling pairs of exomes, 0.5 % of the randomly generated couples were at 25 % risk of having an affected offspring for an autosomal recessive disorder based on the ClinVar variants.

Conclusions: By investigating reported pathogenic and novel, predicted deleterious variants we estimated the lower and upper limits of the population fraction for which exome sequencing may reveal additional medically relevant information. We suggest that the observed wide range for the lower and upper limits of these frequency numbers will be gradually reduced due to improvement in classification databases and prediction algorithms.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Assigned ethnicity by study origin for 8554 ARIC and 2514 CMG individuals
Fig. 2
Fig. 2
Distribution of the number of annotated variants per individual in 56 ACMG SF genes. a Rare nonsynonymous variants. b Predicted deleterious variants
Fig. 3
Fig. 3
Distribution of the number of reported pathogenic variants per individual in 56 ACMG SF genes according to HGMD-DM (black bars), ClinVar (light gray bars) and combined (dark gray bars) databases
Fig. 4
Fig. 4
Distribution of the number of variants per individual in autosomal recessive disease genes. a Rare nonsynonymous variants. b Predicted deleterious variants
Fig. 5
Fig. 5
Distribution of the number of reported pathogenic variants per individual in autosomal recessive disease genes according to HGMD-DM (black bars), ClinVar (light gray bars), and combined (dark gray bars) databases
Fig. 6
Fig. 6
Distributions of the number of annotated nonsynonymous variants among ethnic groups in 56 ACMG SF genes (a) and in autosomal recessive disease genes (b)

References

    1. Mackie FL, Carss KJ, Hillman SC, Hurles ME, Kilby MD. Exome sequencing in fetuses with structural malformations. J Clin Med. 2014;3:747–62. doi: 10.3390/jcm3030747. - DOI - PMC - PubMed
    1. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med. 2013;369:1502–11. doi: 10.1056/NEJMoa1306555. - DOI - PMC - PubMed
    1. O’Daniel JM, Lee K. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling. Cancer J Sudbury Mass. 2012;18:287–92. doi: 10.1097/PPO.0b013e318262467e. - DOI - PubMed
    1. Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med. 2014;20:682–8. doi: 10.1038/nm.3559. - DOI - PMC - PubMed
    1. Morrison AC, Bare LA, Chambless LE, Ellis SG, Malloy M, Kane JP, et al. Prediction of coronary heart disease risk using a genetic risk score: the atherosclerosis risk in communities study. Am J Epidemiol. 2007;166:28–35. doi: 10.1093/aje/kwm060. - DOI - PubMed

LinkOut - more resources